Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Horizon Therapeutics jumps after confirming takeover talks with 3 parties

Published 11/29/2022, 05:23 PM
Updated 11/29/2022, 05:29 PM
© Reuters.  Horizon Therapeutics (HZNP) jumps after confirming takeover talks with 3 parties

© Reuters. Horizon Therapeutics (HZNP) jumps after confirming takeover talks with 3 parties

By Investing.com Staff

Shares of Horizon Therapeutics (NASDAQ:HZNP) surged over 30% after-hours Tuesday after the company confirmed that it was "highly preliminary" takeover talks with Amgen (NASDAQ:AMGN), Janssen Global Services, LLC (NYSE:JNJ) and Sanofi (NASDAQ:SNY).

The confirmation followed shortly after a Wall Street Journal article reported that the biopharma company was fielding takeover interest from large pharmaceutical companies. The Journal story added that with a typical takeover premium it could fetch a price well over $20 billion in a deal.

Horizon said the talks with the three parties "may or may not lead to an offer being made for the entire share capital of the Company."

The company was forced to make the disclosure in accordance with Rule 2.6 of the Irish Takeover Rules, where it is based.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.